Forsyth I A
Baillieres Clin Endocrinol Metab. 1991 Dec;5(4):809-32. doi: 10.1016/s0950-351x(10)80016-3.
In vivo studies have shown that the growth of the mammary gland is regulated by a complex synergistic interaction of protein, steroid and thyroid hormones, but it has proved difficult to fully reproduce these effects in vitro. It is becoming apparent that the hormones classically recognized as involved in mammary growth (oestrogen, progesterone, prolactin, GH, adrenal corticoids, triiodothyronine) bring about effects on epithelial cell proliferation at least in part through growth factors produced at distant sites (such as the liver) and also locally by mammary tissue, both parenchyma and stroma. Growth factor receptors can be demonstrated in mammary tissue. Receptor occupancy generates intracellular signals which enable cells to progress through the cell cycle, leading in ways still not understood to DNA synthesis and cell division. Within the mammary gland there probably exists a balance of stimulatory factors (such as IGFs and EGF/TGF-alpha) and inhibitory factors (such as TGF-beta). Interactions between epithelial and stromal cells, involving growth factors and the extracellular matrix, bring about pattern formation. Growth factors may also play some part in mammary differentiation and function, although the evidence here is less clear. Growth factors are also implemented in the failure of growth regulation which neoplastic transformation represents. Breast cancer cells can synthesize and secrete a variety of growth factors which may stimulate tumour growth through local autocrine/paracrine mechanisms. The oestrogen dependence of some breast cancers may involve oestrogen regulation of and interaction with growth factors, progression to hormone independence involving loss of this control. It is significant that the proteins which protooncogenes encode include growth factors and growth factor receptors. Much remains to be learnt about the nature and control of growth factors produced by and acting on the mammary gland. In breast cancer, this research offers the possibility of new methods of diagnosis and treatment.
体内研究表明,乳腺的生长受蛋白质、类固醇和甲状腺激素复杂的协同相互作用调节,但已证明在体外很难完全重现这些效应。越来越明显的是,传统上认为参与乳腺生长的激素(雌激素、孕激素、催乳素、生长激素、肾上腺皮质激素、三碘甲状腺原氨酸)至少部分地通过远处部位(如肝脏)以及乳腺组织(实质和间质)局部产生的生长因子对上皮细胞增殖产生影响。乳腺组织中可检测到生长因子受体。受体占据会产生细胞内信号,使细胞能够在细胞周期中进展,以仍不清楚的方式导致DNA合成和细胞分裂。在乳腺内可能存在刺激因子(如胰岛素样生长因子和表皮生长因子/转化生长因子-α)和抑制因子(如转化生长因子-β)之间的平衡。上皮细胞与间质细胞之间涉及生长因子和细胞外基质的相互作用导致模式形成。生长因子在乳腺分化和功能中可能也起一定作用,尽管这方面的证据尚不明确。生长因子也与肿瘤转化所代表的生长调节失败有关。乳腺癌细胞可以合成和分泌多种生长因子,这些生长因子可能通过局部自分泌/旁分泌机制刺激肿瘤生长。一些乳腺癌对雌激素的依赖可能涉及雌激素对生长因子的调节以及与生长因子的相互作用,向激素非依赖性的进展涉及这种控制的丧失。重要的是,原癌基因编码的蛋白质包括生长因子和生长因子受体。关于乳腺产生的以及作用于乳腺的生长因子的性质和控制,仍有许多有待了解。在乳腺癌方面,这项研究为新的诊断和治疗方法提供了可能性。